Variant report
Variant | nsv977401 |
---|---|
Chromosome Location | chr13:69782667-69793555 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr13:69785870-69785881 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | E2F4 | chr13:69786236-69786418 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr13:69788203-69788543 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr13:69788210-69788542 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr13:69788343-69788479 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr13:69788204-69788550 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | GATA3 | chr13:69792733-69792913 | SH-SY5Y | brain: | n/a | n/a |
8 | GATA3 | chr13:69784976-69785172 | SH-SY5Y | brain: | n/a | n/a |
9 | MAFK | chr13:69791076-69791109 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | MAFK | chr13:69791134-69791267 | HepG2 | liver: | n/a | chr13:69791178-69791192 chr13:69791175-69791195 chr13:69791177-69791193 |
11 | MAFK | chr13:69791201-69791214 | HepG2 | liver: | n/a | n/a |
12 | POLR2A | chr13:69787516-69788048 | H1-neurons | neurons: | n/a | n/a |
13 | POLR2A | chr13:69784081-69784193 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr13:69787496-69788061 | H1-neurons | neurons: | n/a | n/a |
15 | POLR2A | chr13:69782281-69782779 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | STAT3 | chr13:69785312-69785489 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | STAT3 | chr13:69788290-69788490 | MCF10A-Er-Src | breast: | n/a | chr13:69788427-69788438 |
18 | STAT3 | chr13:69788350-69788550 | MCF10A-Er-Src | breast: | n/a | chr13:69788427-69788438 |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LINC00383 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568228476 | chr13:69782677-69782678 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111691195 | chr13:69782695-69782696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375684609 | chr13:69782724-69782725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7992183 | chr13:69782725-69782726 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs576518949 | chr13:69782731-69782732 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545537119 | chr13:69782738-69782739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7992374 | chr13:69782816-69782817 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs12871270 | chr13:69782842-69782843 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs565849703 | chr13:69782868-69782869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541828845 | chr13:69782910-69782911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539977049 | chr13:69782928-69782929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561948275 | chr13:69782931-69782932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7358906 | chr13:69782995-69782996 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs547611305 | chr13:69782998-69782999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570700324 | chr13:69783038-69783039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533153868 | chr13:69783086-69783087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552361092 | chr13:69783109-69783110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569349052 | chr13:69783113-69783114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372444362 | chr13:69783114-69783115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35048557 | chr13:69783115-69783116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs397754345 | chr13:69783116-69783117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537834809 | chr13:69783181-69783182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554973948 | chr13:69783186-69783187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185215747 | chr13:69783187-69783188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534260527 | chr13:69783228-69783229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554051231 | chr13:69783229-69783230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188208936 | chr13:69783234-69783235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540047811 | chr13:69783238-69783239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537410755 | chr13:69783280-69783281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556118832 | chr13:69783302-69783303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs118155209 | chr13:69783304-69783305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573081202 | chr13:69783313-69783314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs180733751 | chr13:69783317-69783318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554514185 | chr13:69783334-69783335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561713117 | chr13:69783344-69783345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572362795 | chr13:69783378-69783379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541288284 | chr13:69783391-69783392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566425151 | chr13:69787611-69787612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182002367 | chr13:69787615-69787616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187107508 | chr13:69787663-69787664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1591532 | chr13:69787680-69787681 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs552454778 | chr13:69787681-69787682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6562560 | chr13:69787688-69787689 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs538063269 | chr13:69787691-69787692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190726069 | chr13:69787695-69787696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374917674 | chr13:69787743-69787744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145685098 | chr13:69787766-69787767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557166626 | chr13:69787790-69787791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201396416 | chr13:69787793-69787794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553452774 | chr13:69787796-69787797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:69778200-69783000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr13:69782200-69783000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr13:69782400-69782800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr13:69782400-69782800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr13:69782400-69783400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr13:69782600-69782800 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr13:69782800-69783000 | Weak transcription | H9 Cell Line | embryonic stem cell |
8 | chr13:69783000-69783200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr13:69787600-69788000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:69788800-69789200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr13:69789000-69789200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |